ERBB2 and breast carcinoma: In addition, Trono et al. found the hMENA11a isoform sustains cell proliferation and survival in HER2-overexpressing breast cancer cells primarily through activating the HER3/AKT axis, and contributes to HER3-mediated resistance mechanisms to PI3K inhibitors [21].